New Mexico Drug Testing Laws for Employers

No Testing Statute at All

No comprehensive New Mexico statute governing private-employer drug and alcohol testing was located. Nothing sets a probable-cause standard, requires state approval of a policy, imposes a notice period, mandates a laboratory or a medical review officer, or creates a retest right. A national program transfers into New Mexico with fewer changes than almost anywhere else on this site.

The Cannabis Statute Works For You Here

Section 34 of the Cannabis Regulation Act, titled employer protections and exemptions, preserves an employer's ability to prohibit or take adverse action for impairment by, or possession or use of, intoxicating substances at work or during work hours — and expressly preserves the right to adopt and implement a written zero-tolerance policy regarding cannabis products.

It then goes further than any other adult-use state on this site: such a policy "may permit the discipline or termination of an employee on the basis of a positive drug test that indicates any amount of delta-9-tetrahydrocannabinol or delta-9-tetrahydrocannabinol metabolite."

Most adult-use states move in the opposite direction, either barring action on inactive metabolites or protecting off-duty use. New Mexico names the metabolite and authorizes acting on it. Note the framing though: the right is built around a written policy. If yours is not written down, you are relying on a provision whose precondition you have not met.

The Live Risk Is the Medical Program

NMSA 1978 26-2B-9, titled employment protections, provides that unless failing to do so would cost the employer a monetary or licensing-related benefit under federal law or regulations, it is unlawful to take an adverse employment action against an applicant or employee based on conduct allowed under the Lynn and Erin Compassionate Use Act.

Subsection (B) carves out two things: the employer may still prohibit or act on use of, or impairment by, medical cannabis on the premises or during hours of employment; and the section does not apply to an employee whose employer deems that the employee works in a safety-sensitive position.

Note what 26-2B-9 does not say. It does not provide that a patient cannot be deemed impaired based on metabolites, and it does not address test results as such — unlike Delaware's or Missouri's protections, which reach the result directly.

So the conflict is squarely presented: a written zero-tolerance policy expressly authorizes acting on any amount of metabolite, while 26-2B-9 makes adverse action based on protected conduct unlawful outside safety-sensitive roles. Nothing in either statute says which wins. That appears to turn on case law, it is unsettled, and we are not going to guess at it.

The practical response has two parts. Build a documented safety-sensitive designation for the roles where it is genuinely defensible — the statute commits that determination to the employer, which is useful, but a designation covering everyone invites a challenge. And route known-patient cases to counsel rather than applying the policy mechanically.

Be Careful What You Read About New Mexico

This is worth its own section because it affects anyone researching the state.

Bills that would have banned random cannabis testing, limited testing to reasonable suspicion and post-accident circumstances, required medical review officer review, and deleted the safety-sensitive exception were introduced as 2025 H.B. 230 and again as 2026 S.B. 129. Both were postponed indefinitely. Neither became law.

Because bill text is indexed and published, search results readily surface those provisions as though they described New Mexico law. They do not. Current New Mexico law still expressly permits a written zero-tolerance policy and discipline or termination on a positive showing any amount of THC or THC metabolite.

A similar trap exists on the workers' compensation side, where a 2016 bill that would have rewritten the benefit-reduction statute also died, yet its proposed language is what search engines return.

Workers' Compensation: A Policy-Conditioned Reduction

New Mexico has no drug-free workplace premium credit we could locate. What it has is an indemnity-benefit reduction tied to having a written policy.

Per the New Mexico Workers' Compensation Administration's published Worker Guidebook, NMSA 1978 52-1-12.1 provides for a reduction in indemnity benefits proportional to the degree the worker's intoxication contributed to the incident — anywhere from 10 to 90 percent, determined by a workers' compensation judge. An employer cannot seek a reduction if it knew of the impairment but allowed the worker to remain on the job. And the employer must have a written drug- and alcohol-free workplace policy in place and communicated to workers for any reduction to take effect.

Two cautions we will state plainly. The exact present-day preconditions could not be verified from an accessible official code publisher, because New Mexico's official statute site blocks automated access. In particular, whether an earlier requirement that test results conform to U.S. Department of Transportation procedures and come from a DOT-certified laboratory survives in the current text is something to confirm with counsel or directly with the Administration rather than assume from this page.

A Note on Sourcing

The New Mexico Compilation Commission's public statute site returns an error to automated requests, so it is not cited here. The statutory text on this page comes from the enacted bills published by the New Mexico Legislature, which carry both the operative language and the compiled NMSA section numbers, plus the Workers' Compensation Administration's own publication.

Where This Lands

New Mexico's employment base runs through oil and gas extraction and oilfield services, federal laboratories and defense contracting, healthcare, tourism and food service, film and television production, and construction and hard-rock mining. Federal contracting and the extractive industries both bring the federal-benefit exception into play, which is the cleanest route through the medical-cannabis conflict where it applies.